Submissions from 2018
Myofibromatosis presenting as reticulated vascular changes and subcutaneous atrophy in a patient with somatic mosaicism of PDGFRB mutation., C S Zhong, H Song, A Weiss, W-H Tan, S Coury, and J T Huang
Submissions from 2017
A phase 1 study of the CXCR4 antagonist plerixafor in combination with high-dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or myelodysplastic syndrome: a pediatric oncology experimental therapeutics investigators' consortium study (POE 10-03)., Todd M Cooper, Edward Allan Racela Sison, Sharyn D Baker, Lie Li, Amina Ahmed, Tanya Trippett, Lia Gore, Margaret E Macy, Aru Narendran, Keith August, Michael J Absalon, Jessica Boklan, Jessica Pollard, Daniel Magoon, and Patrick A Brown
Visualization of Cancer and Cardiovascular Disease Co-Occurrence With Network Methods., Christine W Duarte, Volkhard Lindner, Sanjeev A Francis, and Dounya Schoormans
Perioperative chemotherapy versus postoperative chemoradiotherapy in patients with resectable gastric/gastroesophageal junction adenocarcinomas: a survival analysis of 5058 patients., Timothy L Fitzgerald, Jimmy T Efird, Nelly Bellamy, Suzanne M Russo, Charulata Jindal, Catalina Mosquera, Elizabeth G Holliday, and Tithi Biswas
CD33 Splicing Polymorphism Determines Gemtuzumab Ozogamicin Response in De Novo Acute Myeloid Leukemia: Report From Randomized Phase III Children's Oncology Group Trial AAML0531., Jatinder K Lamba, Lata Chauhan, Miyoung Shin, Michael R Loken, Jessica A Pollard, Yi-Cheng Wang, Rhonda E Ries, Richard Aplenc, Betsy A Hirsch, Susana C Raimondi, Roland B Walter, Irwin D Bernstein, Alan S Gamis, Todd A Alonzo, and Soheil Meshinchi
Center-level variation in accuracy of adverse event reporting in a clinical trial for pediatric acute myeloid leukemia: a report from the Children's Oncology Group., Tamara P Miller, Yimei Li, Marko Kavcic, Kelly D Getz, Yuan-Shun V Huang, Lillian Sung, Todd A Alonzo, Robert Gerbing, Marla H Daves, Terzah M Horton, Michael A Pulsipher, Jessica Pollard, Rochelle Bagatell, Alix E Seif, Brian T Fisher, Selina Luger, Alan S Gamis, Peter C Adamson, and Richard Aplenc
Novel nomogram combining depth of invasion and size can accurately predict the risk for regional nodal metastases for appendiceal neuroendocrine tumors (A-NET)., Catalina Mosquera, Timothy L Fitzgerald, Haily Vora, and Marysia Grzybowski
Desmoid tumours in children: when wait-and-see becomes wait-and-treat., Aaron Weiss and Douglas Hawkins
Submissions from 2016
Factors influencing survival among Kenyan children diagnosed with endemic Burkitt lymphoma between 2003 and 2011: A historical cohort study., Geoffrey Buckle, Louise Maranda, Jodi Skiles, John Michael Ong'echa, Joslyn Foley, Mara Epstein, Terry A Vik, Andrew Schroeder, Jennifer Lemberger, Alan Rosmarin, Scot C Remick, Jeffrey A Bailey, John Vulule, Juliana A Otieno, and Ann M Moormann
Factors Affecting Physicians' Intentions to Communicate Personalized Prognostic Information to Cancer Patients at the End of Life: An Experimental Vignette Study., Paul K J Han, Nathan F Dieckmann, Christina Holt, Caitlin Gutheil, and Ellen Peters
Randomized phase II evaluation of bevacizumab versus bevacizumab plus fosbretabulin in recurrent ovarian, tubal, or peritoneal carcinoma: an NRG Oncology/Gynecologic Oncology Group study., Bradley J Monk, Michael W Sill, Joan L Walker, Christopher J. Darus, Gregory Sutton, Krishnansu S Tewari, Lainie P Martin, Jeanne M Schilder, Robert L Coleman, Jai Balkissoon, and Carol Aghajanian
Hypofractionated Conformal Radiotherapy with Concurrent Full-Dose Gemcitabine Versus Standard Fractionation Radiotherapy with Concurrent Fluorouracil for Unresectable Pancreatic Cancer: a Multi-Institution Experience., Sunpreet Rakhra, Jonathan B Strauss, John Robertson, Cornelius J McGinn, Thomas Kim, Jiayi Huang, Andrew Blake, Irene Helenowski, John P Hayes, Mary Mulcahy, and William Small
Submissions from 2015
A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group study., David Bender, Michael W Sill, Heather A Lankes, Henry D Reyes, Christopher J Darus, James E Delmore, Jacob Rotmensch, Heidi J Gray, Robert S Mannel, Jeanne M Schilder, Mark I Hunter, Carolyn K McCourt, Megan I Samuelson, and Kimberly K Leslie
Primary Site Predicts Grade for Gastroenteropancreatic Neuroendocrine Tumors., Timothy L. Fitzgerald, Catalina Mosquera, C Suzanne Lea, and Matthew Mcmullen
Phase II evaluation of dalantercept, a soluble recombinant activin receptor-like kinase 1 (ALK1) receptor fusion protein, for the treatment of recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study 0229N., Vicky Makker, Virginia L Filiaci, Lee-May Chen, Christopher J Darus, James E Kendrick, Gregory Sutton, Katherine Moxley, and Carol Aghajanian
A phase II trial of trebananib (AMG 386; IND#111071), a selective angiopoietin 1/2 neutralizing peptibody, in patients with persistent/recurrent carcinoma of the endometrium: an NRG/Gynecologic Oncology Group trial., Kathleen N Moore, Michael W Sill, Meaghan E Tenney, Christopher J Darus, David Griffin, Theresa L Werner, Peter G Rose, and Robert Behrens
Enhancing Adolescent and Young Adult Oncology Research Within the National Clinical Trials Network: Rationale, Progress, and Emerging Strategies., Aaron R Weiss, Craig R Nichols, and David R Freyer
Submissions from 2014
Systematic review: surgery for patients with metastatic melanoma during active treatment with ipilimumab., Justin J Baker, Karyn B Stitzenberg, Frances A Collichio, Michael O Meyers, and David W Ollila
Intraperitoneal chemotherapy among women in the Medicare population with epithelial ovarian cancer., Kathleen M Fairfield, Kimberly Murray, Jason A LaChance, Heidi R Wierman, Craig C Earle, Edward L Trimble, and Joan L Warren
Acceptability of telemedicine and other cancer genetic counseling models of service delivery in geographically remote settings., Eileen McDonald, Amanda Lamb, Barbara Grillo, Lee Lucas, and Susan Miesfeldt
Breast cancer knowledge, beliefs, and screening practices among women seeking care at district hospitals in Dar es Salaam, Tanzania., Emma Perry Morse, Bertha Maegga, Gertrud Joseph, and Susan Miesfeldt
Next generation sequencing reveals skewing of the T and B cell receptor repertoires in patients with Wiskott-Aldrich syndrome., Amy E O'Connell, Stefano Volpi, Kerry Dobbs, Claudia Fiorini, Erdyni Tsitsikov, Helen de Boer, Isil B Barlan, Jenny M Despotovic, Francisco J Espinosa-Rosales, I Celine Hanson, Maria G Kanariou, Roxana Martínez-Beckerat, Alvaro Mayorga-Sirera, Carmen Mejia-Carvajal, Nesrine Radwan, Aaron R Weiss, Sung-Yun Pai, Yu Nee Lee, and Luigi D Notarangelo
Effect of a dedicated acute care operating room on hospital efficiency., Cecilia Trydestam, Steven Prato, Brad Cushing, and James Whiting
Cryo Surgery of the Prostate: An Effective, Minimally Invasive Cancer Therapy with Superior Health-related Quality-of-Life Outcomes, Martyn A. Vickers Jr
Advances in therapy for pediatric sarcomas., Aaron Weiss, Jonathan Gill, John Goldberg, Joanne Lagmay, Holly Spraker-Perlman, Rajkumar Venkatramani, and Damon Reed
Submissions from 2013
Development and impact of human papillomavirus vaccines., Christopher J Darus and Jennifer J Mueller
Management of genetic syndromes predisposing to gynecologic cancers., Susan Miesfeldt, Amanda Lamb, and Christine Duarte
Submissions from 2010
The general surgery residency at Maine Medical Center., Ajita S Prabhu, Jonathan F Dreifus, and James F Whiting
Submissions from 2008
"Are you at risk for hereditary breast cancer?": development of a personal risk assessment tool for hereditary breast and ovarian cancer., Wendy F Cohn, Susan M Jones, and Susan Miesfeldt
Submissions from 1950
Cystectomy and uretero-intestinal anastomosis for cancer of the bladder, Louis A. Asali
Cystectomy and uretero-intestinal anastomosis for cancer of the bladder, D F. MARSHALL
Transthoracic nephrectomy for metastatic osteogenic sarcoma of the kidney, D F. MARSHALL